Suppr超能文献

肠道酰基辅酶A:胆固醇酰基转移酶活性缺乏的大鼠的正常胆固醇吸收

Normal cholesterol absorption in rats deficient in intestinal acyl coenzyme A:cholesterol acyltransferase activity.

作者信息

Gallo L L, Wadsworth J A, Vahouny G V

出版信息

J Lipid Res. 1987 Apr;28(4):381-7.

PMID:3585173
Abstract

Acyl coenzyme A:cholesterol acyl transferase and/or cholesterol esterase may regulate the esterification and absorption of exogenous cholesterol. To assess this, mucosal acyl coenzyme A:cholesterol acyl transferase activity was inhibited selectively with three different drugs [Sandoz #58-035, inhibitor 1; Lederle inhibitor 2 and inhibitor 3] and the effect upon the absorption of a [4-14C]cholesterol meal was studied in the lymph fistula rat. Compared to control rats, ACAT activity measured in mucosal homogenates from the drug-treated rats was reduced 80-90%, 40%, and 30%, respectively, during the predicted time-frame for maximum mucosal esterification of cholesterol (i.e., after cholesterol is fed and before it appears in lymph). In contrast, [14C]cholesterol absorption in the drug-treated animals was unchanged from controls [5.7 +/- 1.2 (inhibitor 1) vs. 5.4 +/- 1.6 mumol/6 hr (control); 6.1 +/- 2.1 (inhibitor 2) and 5.2 +/- 1.5 (inhibitor 3) vs. 4.1 +/- 1.3 mumol/6 hr (control)]. Of the absorbed [14C]cholesterol, approximately 75% was esterified in all groups. Cholesterol esterase activity measured in the drug-treated rats was unchanged compared to controls nor did the drugs inhibit this enzyme in vitro. Under the conditions of this study, drugs causing substantial inhibition of acyl coenzyme A:cholesterol acyl transferase activity had no effect on the absorption of exogenous cholesterol.

摘要

酰基辅酶A:胆固醇酰基转移酶和/或胆固醇酯酶可能调节外源性胆固醇的酯化和吸收。为了评估这一点,用三种不同的药物[Sandoz #58 - 035,抑制剂1;Lederle抑制剂2和抑制剂3]选择性抑制黏膜酰基辅酶A:胆固醇酰基转移酶活性,并在淋巴瘘大鼠中研究其对[4 - 14C]胆固醇餐吸收的影响。与对照大鼠相比,在预测的胆固醇最大黏膜酯化时间范围内(即喂食胆固醇后且其出现在淋巴之前),药物处理大鼠的黏膜匀浆中测得的ACAT活性分别降低了80 - 90%、40%和30%。相比之下,药物处理动物的[14C]胆固醇吸收与对照相比没有变化[5.7±1.2(抑制剂1)对5.4±1.6 μmol/6小时(对照);6.1±2.1(抑制剂2)和5.2±1.5(抑制剂3)对4.1±1.3 μmol/6小时(对照)]。在所有组中,吸收的[14C]胆固醇中约75%被酯化。与对照相比,药物处理大鼠中测得的胆固醇酯酶活性没有变化,并且这些药物在体外也不抑制该酶。在本研究条件下,能显著抑制酰基辅酶A:胆固醇酰基转移酶活性的药物对外源性胆固醇的吸收没有影响。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验